BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 6388822)

  • 1. A comparison of the effect of selenium on the mutagenicity and metabolism of benzo[a]pyrene in rat and hamster liver S9 activation systems.
    Teel RW
    Cancer Lett; 1984 Oct; 24(3):281-9. PubMed ID: 6388822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenium modified mutagenicity and metabolism of benzo[a]pyrene in an S9-dependent system.
    Teel RW; Kain SR
    Mutat Res; 1984 Jun; 127(1):9-14. PubMed ID: 6328289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glucose administration on hamster liver S9-mediated mutagenesis, metabolism and DNA-binding of benzo[a]pyrene and aflatoxin B1.
    Rubano DC; Teel RW; Strother A
    Cancer Lett; 1990 Jul; 52(2):123-31. PubMed ID: 2116220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selenium inhibition of benzo[a]pyrene, 3-methylcholanthrene, and 3-methylcholanthrylene mutagenicity in Salmonella typhimurium strains TA98 and TA100.
    Prasanna P; Jacobs MM; Yang SK
    Mutat Res; 1987 Feb; 190(2):101-5. PubMed ID: 3547113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and detoxication of promutagens by toadfish (Opsanus tau) hepatic postmitochondrial fractions in the Salmonella assay.
    Milling DM; Maddock MB
    Mutat Res; 1986 Apr; 164(2):81-9. PubMed ID: 3515163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of 1-nitrobenzo[a]pyrene by rat liver microsomes to potent mutagenic metabolites.
    Chou MW; Heflich RH; Fu PP
    Carcinogenesis; 1986 Nov; 7(11):1837-44. PubMed ID: 3769131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of rat lymphocyte activation of benzo[a]pyrene, 2-acetylaminofluorene, and several of their metabolites to mutagenic and DNA-damaging species in vitro.
    Gao N; Aidoo A; Heflich RH
    Teratog Carcinog Mutagen; 1991; 11(2):65-76. PubMed ID: 1686675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
    Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
    Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese medicinal herbs modulate mutagenesis, DNA binding and metabolism of benzo[a]pyrene 7,8-dihydrodiol and benzo[a]pyrene 7,8-dihydrodiol-9,10-epoxide.
    Wong BY; Lau BH; Teel RW
    Cancer Lett; 1992 Feb; 62(2):123-31. PubMed ID: 1540939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
    Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
    Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsomal activation of 1- and 3-nitrobenzo[a]pyrene to mutagens in Chinese hamster ovary cells.
    Thornton-Manning JR; Chou MW; Fu PP; Heflich RH
    Mutagenesis; 1988 May; 3(3):233-7. PubMed ID: 3045485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenic activity of the 4,5- and 9,10-dihydrodiols of benzo[j]fluoranthene and their syn- and anti-dihydrodiol epoxides in Salmonella typhimurium.
    Marshall MV; He ZM; Weyand EH; Rice JE; LaVoie EJ
    Environ Mol Mutagen; 1993; 22(1):34-45. PubMed ID: 8339723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsomal metabolism of 1-nitrobenzo[e]pyrene to a highly mutagenic K-region dihydrodiol.
    Fu PP; Heflich RH; Von Tungeln LS; Miranda HZ; Evans FE
    Carcinogenesis; 1988 Jun; 9(6):951-8. PubMed ID: 3286032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple metabolic pathways for the mutagenic activation of 3-nitrobenzo[a]pyrene.
    Chou MW; Heflich RH; Fu PP
    Carcinogenesis; 1985 Aug; 6(8):1235-8. PubMed ID: 3893788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of 7,8-dihydrobenzo(a)pyrene by rat liver microsomal enzymes and mutagenicity of metabolites.
    Chiu PL; Yang SK
    Cancer Res; 1986 Oct; 46(10):5084-94. PubMed ID: 3756866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative mutagenicity tests in the Salmonella/microsome assay with rat and woodchuck S9 preparations.
    Rashid KA; Babish JG; Johnson BE; Mumma RO
    Toxicology; 1985 Aug; 36(2-3):139-46. PubMed ID: 3931301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of glucose-6-phosphate dehydrogenase deficiency on the formation of mutagenic and carcinogenic metabolites derived from benzo(a)pyrene.
    Pirisi L; Garcea R; Pascale R; Ruggiu ME; Feo F
    Toxicol Pathol; 1987; 15(1):115-9. PubMed ID: 3576073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish.
    Guobaitis RJ; Ellingham TJ; Maddock MB
    Mutat Res; 1986 Feb; 164(1):59-70. PubMed ID: 3512989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of liver microsome-mediated mutagenesis, metabolism and DNA-binding of benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol in the rat following glucose administration.
    Vance RE; Teel RW; Strother A
    Cancer Lett; 1990 Apr; 50(2):149-56. PubMed ID: 2109652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial mutagenicity of some tobacco aromatic nitrogen bases and their mixtures.
    Yim SH; Hee SS
    Mutat Res; 2001 May; 492(1-2):13-27. PubMed ID: 11377240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.